1. Home
  2. AERT vs COEP Comparison

AERT vs COEP Comparison

Compare AERT & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AERT
  • COEP
  • Stock Information
  • Founded
  • AERT 2012
  • COEP 2017
  • Country
  • AERT Singapore
  • COEP United States
  • Employees
  • AERT N/A
  • COEP N/A
  • Industry
  • AERT Professional Services
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AERT Consumer Discretionary
  • COEP Health Care
  • Exchange
  • AERT Nasdaq
  • COEP Nasdaq
  • Market Cap
  • AERT 33.5M
  • COEP 32.4M
  • IPO Year
  • AERT N/A
  • COEP N/A
  • Fundamental
  • Price
  • AERT $0.61
  • COEP $11.54
  • Analyst Decision
  • AERT
  • COEP
  • Analyst Count
  • AERT 0
  • COEP 0
  • Target Price
  • AERT N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • AERT 59.8K
  • COEP 135.7K
  • Earning Date
  • AERT 02-19-2025
  • COEP 03-25-2025
  • Dividend Yield
  • AERT N/A
  • COEP N/A
  • EPS Growth
  • AERT N/A
  • COEP N/A
  • EPS
  • AERT N/A
  • COEP N/A
  • Revenue
  • AERT $72,141,000.00
  • COEP N/A
  • Revenue This Year
  • AERT N/A
  • COEP N/A
  • Revenue Next Year
  • AERT N/A
  • COEP N/A
  • P/E Ratio
  • AERT N/A
  • COEP N/A
  • Revenue Growth
  • AERT 16.98
  • COEP N/A
  • 52 Week Low
  • AERT $0.51
  • COEP $2.31
  • 52 Week High
  • AERT $2.93
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • AERT 34.83
  • COEP 59.40
  • Support Level
  • AERT $0.53
  • COEP $8.65
  • Resistance Level
  • AERT $0.65
  • COEP $13.70
  • Average True Range (ATR)
  • AERT 0.11
  • COEP 2.11
  • MACD
  • AERT -0.02
  • COEP -0.24
  • Stochastic Oscillator
  • AERT 13.90
  • COEP 61.22

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: